10-K Decoder · All companies

Definium Therapeutics, Inc.

DFTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$166M−$104M−60.0%
Net income−$184M−$109M−69.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$72.3M−$45.7M−58.2%
Net income−$51.0M−$67.3M+24.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Definium's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
Was Definium profitable in FY2025?
No: net income was −$184M and operating income −$166M in FY2025.
What was Definium's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 9, 2026.